Literature DB >> 7385102

A comparison of the major platelet membrane glycoproteins from Bernard-Soulier syndrome with normals after radiolabelling of sialic acid or terminal galactose/N-acetylgalactosamine residues.

J L McGregor, K J Clemetson, E James, E F Luscher, M Dechavanne.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7385102     DOI: 10.1016/0049-3848(80)90374-6

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  5 in total

1.  The trans-sialidase from Trypanosoma cruzi induces thrombocytopenia during acute Chagas' disease by reducing the platelet sialic acid contents.

Authors:  María Virginia Tribulatti; Juan Mucci; Nico Van Rooijen; María Susana Leguizamón; Oscar Campetella
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

2.  Platelet surface antigens: analysis by monoclonal antibodies. I. Antibodies. I. Immunological and biochemical studies.

Authors:  S Santoso; J Lohmeyer; H Rennich; K J Clemetson; C Mueller-Eckhardt
Journal:  Blut       Date:  1984-03

3.  Characterization of the platelet membrane glycoprotein abnormalities in Bernard-Soulier syndrome and comparison with normal by surface-labeling techniques and high-resolution two-dimensional gel electrophoresis.

Authors:  K J Clemetson; J L McGregor; E James; M Dechavanne; E F Lüscher
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

4.  Platelet biogenesis and functions require correct protein O-glycosylation.

Authors:  Yingchun Wang; Shawn M Jobe; Xiaokun Ding; Hyojung Choo; David R Archer; Rongjuan Mi; Tongzhong Ju; Richard D Cummings
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-17       Impact factor: 11.205

5.  Analysis of the glycoprotein and protein composition of Bernard-Soulier platelets by single and two-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  A T Nurden; D Dupuis; T J Kunicki; J P Caen
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.